John Villafranco Quoted in Pharma Intelligence

Partner John Villafranco is quoted in Pharma Intelligence discussing the FTC’s updated guidance for health products. John states that the FTC’s Health Products Compliance Guidance is a sweeping overhaul” of its predecessor and a continuation of the agency’s decade-long march toward a drug-like substantiation standard for non-drug product claims.

This updated guidance synthesizes the agency’s approach and seeks to put broad swaths of the health and personal care industries on notice that FTC staff is attempting to raise the bar for substantiation, even though prior attempts to do so through litigation have been rejected by certain courts,”

You can read the full article here.